Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777686 · ClinicalTrials.gov registry record
Measuring Non-Enhancing Glioblastoma Progression
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 7
- Enrollment target
NCT00777686: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00777686 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00777686 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if magnetic resonance imaging with magnetic resonance spectroscopy ("MRI/MRS" scanning) can measure any extra growth in the tumor that does not show up on regular MRI images. This study procedure will be performed on patients with recurrent glioblastoma who are either being treated with chemotherapy that blocks blood vessel growth, or will soon begin this type of chemotherapy.
Interventions
- PROCEDURE MRI/MRS Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00777686
The ClinicalTrials.gov registry entry for NCT00777686 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI/MRS Scan is the first listed.
NCT00777686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00777686 about?
NCT00777686 is a clinical study titled "Measuring Non-Enhancing Glioblastoma Progression". The goal of this clinical research study is to learn if magnetic resonance imaging with magnetic resonance spectroscopy ("MRI/MRS" scanning) can measure any extra growth in the tumor that does not show up on regular MRI images. This study procedure will be performed on patients with recurrent gliobl...
What is the current status of trial NCT00777686?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2008-08. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00777686?
The interventions under investigation include: MRI/MRS Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00777686?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.